Baxter International Investor Relations Material

Baxter International Inc. is an American healthcare company with global operations. The company has a focus on kidney disease and various chronic illnesses. Baxter International operates under two different segments: BioScience and Medical Products. The first of these two produces various medications, while the latter provides equipment and products used for the treatment of patients in hospitals and care facilities. The company is headquartered in Deerfield, Illinois, and its shares trade on the NYSE.

Founded in 1931 by Dr. Donald Baxter, Baxter International Inc. was initiated as a small enterprise manufacturing and distributing intravenous (IV) therapy solutions. Over its history, the company has expanded significantly, evolving into a global healthcare leader providing a wide array of medical products and services crucial for patient care. Baxter has been particularly influential in renal care, nutritional therapies, advanced surgical technologies, and critical care products. Companies operating in a similar field include names like Abbott Laboratories, Medtronic, and Fresenius Medical Care.

Baxter BioScience is a division of Baxter International Inc. that specializes in the research, development, and production of biopharmaceuticals. The division produces a range of products for the treatment of hemophilia and other bleeding disorders. These include clotting factor replacements, which are proteins typically missing or deficient in patients with hemophilia. By providing these therapies, Baxter BioScience assists patients in managing and mitigating bleeding events.

In addition, the division manufactures immunoglobulin therapies. These are employed in the treatment of immune deficiencies and other autoimmune diseases. By supplying patients with a regular source of the necessary antibodies, these therapies can help modulate or supplement the patient's immune system.

The Medical Products division specializes in the development and distribution of essential medical devices and pharmaceuticals used across various healthcare settings.

One of its core product areas is renal care. Baxter offers a comprehensive range of products for peritoneal dialysis and hemodialysis. Examples include PD cyclers, solutions, and related consumables, which help patients with chronic kidney disease manage their condition.

Additionally, Baxter Medical Products provides intravenous (IV) therapies, systems, and administrative sets. These IV products range from basic saline solutions to more specialized medications. They are integral to hospitals, clinics, and other medical facilities for delivering fluids, medications, and nutrients directly into patients' veins. The division also offers products for parenteral nutrition, assisting patients who cannot consume food normally. These nutritional products are formulated to meet specific dietary needs and are delivered intravenously. Moreover, Baxter Medical Products provides various infusion pumps and systems.